Study ID | Study groups | Age (years) Mean (SD) | Gender (males) Number, percentage | The onset of hyperthyroidism (years) Mean (SD) | Mean thyroid volume (ml) Mean (SD) | Mean serum TSH (mIU/l) Mean (SD) |
---|---|---|---|---|---|---|
Randomized controlled trials | ||||||
Thamcharoenvipas et al 2019 | Intervention 1 | 30 (7.4) | 3, 15% | 21.3 (32.6) | 82.6 (30.4) | .005 (.006) |
Intervention 2 | 34.3 (13) | 1, 5% | 30.3 (39.3) | 87.1 (21.0) | .011 (.02) | |
control | 31.8 (12.2) | 8, 40% | 15.2 (19.6) | 98.9 (36.0) | .003 (.004) | |
Hammond et al. 2016 | intervention | 43.7 (13.2) | 9, 10% | NA | NA | .05 |
control | 48.4 (12.0) | 11, 14.7% | NA | NA | .04 | |
Lingudu et al. 2014 | intervention | 35.9 (7.5) | 2, 10% | 19.7 (21) | 26.7 (15.8) | NA |
control | 37.3 (12.7) | 9, 45% | 15.5 (10.8) | 28.2 (12.4) | NA | |
Bal et al. 2002 | intervention | 41.8 (12.2) | 61, 37.2% | 6.1 (47.9) | 48 (29.0) | NA |
control | 41.8 (11.5) | 54, 35.5% | 45.4 (41.6) | 45 (24.0) | NA | |
Bogazzi et al. 2002 | Intervention 1 | 48.0 (9.0) | 2, 16.7% | 37.3 (2.4) | 19 (10) | 1.3 (1.3) |
Intervention 2 | 51.0 (9.0) | 3, 25% | 5.7 (2.0) | 21 (11.0) | 1.4 (1.7) | |
control | 52.0 (13.0) | 4, 33.4% | 5.3 (1.8) | 24 (13.0) | 2.3 (1.8) | |
Bogazzi et al. 1999 | Intervention | 45 (12.8) | 10, 18.5% | 6.1 (2.3) | 38 (22.0) | .6 (1.0) |
Control | 51 (15.8) | 9, 16.7% | 5.7 (2.3) | 35 (21.0) | .4 (.9) | |
Non-randomized controlled trials | ||||||
Sekulić et al 2017 | Intervention | 53.9 (8.8) | 5, 16.7% | 84.2 (68.0) | NA | .9 (.6) |
Control | 51.3 (9.2) | 6, 20% | 72.6 (52.6) | NA | .9 (.88) | |
Oszukowska et al 2010 | Intervention | 52.1 (13.1) | 29 (14.5%) | NA | NA | NA |
Control | NA | NA | NA | |||
TURNER et al 1976 | Intervention | 44 (10.3) | 5, 31.3% | NA | NA | NA |
Control | 43 (7.8) | 2, 12.5% | NA | NA | NA |